Aurion Biotech Receives Approval From Japan’s PMDA For New Drug Application

Aurion Biotech announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency, for its novel cell therapy, VyznovaTM for the treatment of bullous keratopathy of the cornea.